Meta-analysis of the hallmark cardiovascular and renal outcome trials addressing the risk for respiratory tract infections with sodium-glucose co-transporter-2 inhibitors: Implications for the COVID-19 pandemic.

ABSTRACT:

SUBMITTER: Patoulias D 

PROVIDER: S-EPMC8014812 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature